甲基化提里拉扎德可以减轻马匹的橄果糖诱导的细菌炎
Maimaiti Tuniyazi1, Ruibo Tang1, Xiaoyu Hu1
1College of Veterinary Medicine, Jilin University, Changchun, China.
Frontiers in microbiology
|October 10, 2024
概括
甲基化里拉扎德 (PTP-102) 通过改善临床症状,血液标志物和皮组织损伤,有效地治疗了马匹的橄果糖诱导的细菌炎. 它还对肠道微生物群产生了积极的影响,在治疗中表现出比预防更大的疗效.
科学领域:
- 马的健康 马的健康
- 兽医医学 兽医医学 兽医医学
- 微生物组研究 微生物组研究
背景情况:
- 马体内炎会引起严重的疼痛和,通常是由于复杂的炎症和肠道失调.
- 之前的研究将肠道微生物群代谢物和状伤与拉米尼斯炎的发展联系起来.
- 矩阵金属蛋白酶与膜炎有关,而甲基化利拉扎德在体外显示了层状组织修复的潜力.
研究的目的:
- 为了研究甲基化里拉扎德 (PTP-102) 在预防和治疗马匹的橄果糖诱导的细菌炎的疗效.
- 评估甲基化提里拉扎德对临床症状,血液指数,皮组织损伤和肠道微生物群组成的影响.
主要方法:
- 橄果糖被用于诱导马的拉米尼斯,随后进行甲基化利拉扎德的干预.
- 分析了临床症状,血液标志物,部组织损伤 (通过剖析和染色),以及肠道微生物群.
- 这项研究比较了甲基化利拉扎德的预防和治疗.
主要成果:
- 橄果糖成功诱导了细膜炎,其特征是临床症状,血液指数升高和皮组织损伤.
- 甲基化提里拉扎德的干预显著改善了临床症状,血液标志物,并减少了叶片组织损伤.
- 用甲基化利拉扎德治疗积极调节肠道微生物群,减少有害细菌,并在治疗组显示出更好的结果.
结论:
- 甲基化提里拉扎德 (PTP-102) 是有效的预防和治疗马类细膜炎,具有显著的治疗效用后诊断.
- 药物的机制可能涉及肠道微生物群的积极调节以及直接的组织修复效应.
- 进一步研究甲基化利拉扎德在马类细膜炎管理中的作用是有必要的.
更多相关视频
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Microbes in the Production of Fermented Foods
Lactic acid bacteria (LAB) and molds are instrumental in fermenting plant-based foods to enhance preservation and ensure year-round availability. These microbial processes convert plant carbohydrates into organic acids and other metabolites that inhibit spoilage organisms and contribute to the sensory qualities of the final product.In sauerkraut production, cabbage goes through a microbial succession that starts with cocci such as Leuconostoc mesenteroides. These microbes begin fermentation by...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


